跳至主要内容
临床试验/NCT02907944
NCT02907944已完成不适用

Working With HIV Clinics to Adopt Addiction Treatments Using Implementation Facilitation (WHAT-IF?)

Yale University8 个研究点 分布在 1 个国家目标入组 3,838 人开始时间: 2016年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
3,838
试验地点
8
主要终点
Change in Provision of Addiction Treatments

研究概览

简要总结

Tobacco, alcohol and opioid use disorders threaten the health of HIV-infected patients. What if evidence-based counseling and medication treatments for tobacco, alcohol and opioid use disorders (herein refered to as addiction treatments) were routinely provided in HIV clinics? Implementation Facilitation is an established strategy to increase the uptake of evidence-based treatments. Our goal is to evaluate the impact of Implementation Facilitation on the use of addiction treatments in four large HIV clinics.

The purpose of the WHAT-IF study is:

Aim 1. Among key stakeholders, to use quantitative and qualitative (mixed) methods to identify the site-specific evidence, context and facilitation-related barriers and facilitators to the integration of addiction treatments to help tailor an Implementation Facilitation for each clinic.

Aim 2. To evaluate the impact of Implementation Facilitation on:

2a: Organizational readiness to deliver addiction treatments 2b: Provider readiness to deliver addiction treatments 2c: Provision of addiction treatments 2d: Changes in organizational models of care used to deliver addiction treatments

Aim 3. To evaluate the impact of Implementation Facilitation on antiretroviral therapy receipt, HIV viral suppression, VACS Index, and retention in HIV care among patients eligible for addiction treatment.

详细描述

The Working with HIV clinics to adopt Addiction Treatments using Implementation Facilitation (WHAT IF?) study will evaluate the impact of Implementation Facilitation on the adoption of addiction treatment services in four HIV clinics. We will use a stepped wedge design . The primary comparison is of the change that occurs from the pre-implementation period to two post-implementation periods, the initial six months (evaluation) and the following six months (maintenance). This proposal will consist of three main components in each of four clinics: 1) formative evaluation with key stakeholders at each site to guide and refine the Implementation Facilitation, 2) conduct of the Implementation Facilitation and 3) an evaluation of the impact of the Implementation Facilitation on organization and provider-level readiness, provision of addiction treatments, and HIV outcomes.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient inclusion criteria:
  • HIV-infected
  • Receiving HIV care in the index clinic
  • Age >18 years old
  • Meets criteria for lifetime or current tobacco, alcohol and/or opioid use disorder regardless of addiction treatment status
  • Able to provide verbal informed consent
  • Staff inclusion criteria:
  • Employed at participating HIV clinic for at least 6 months
  • Able to provide verbal informed consent.
  • Payer/health insurance provider inclusion criteria:
  • Employed at an organization or agency that provides funding for medical services for HIV-infected individuals for at least 6 months.
  • Able to provide verbal informed consent.

排除标准

  • Unable to provide verbal informed consent

结局指标

主要结局

Change in Provision of Addiction Treatments

时间窗: Baseline, 12 months

Study team will use the electronic medical record to identify prescriptions for each of the target medications in the surveillance period. Study team will use CPT codes to determine whether specific counseling therapies were provided. Patients diagnosed with Opioid Use Disorder and/or Alcohol Use Disorder and/or Tobacco Use Disorder were identified and then assessed in the EHR to determine if medication assisted therapy was provided by a provider during the 12 month Evaluation period.

次要结局

  • Antiretroviral Therapy (ART) Receipt(12 months)
  • VACS Index(12 months)
  • Viral Suppression(12 months)
  • Provider Readiness(6 months)
  • Provider Readiness:(12 months)
  • Retention in HIV Care(12 months)
  • Organizational Readiness(12 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验